Halozyme Therapeutics
HALO
#2111
Rank
โ‚ฌ7.14 B
Marketcap
56,15ย โ‚ฌ
Share price
-2.42%
Change (1 day)
60.06%
Change (1 year)

Halozyme Therapeutics (HALO) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ0.62 Billion

According to Halozyme Therapeutics's latest financial reports the company has โ‚ฌ0.62 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ0.30 B-10.13%
2022-12-31โ‚ฌ0.33 B-48.3%
2021-12-31โ‚ฌ0.65 B118.66%
2020-12-31โ‚ฌ0.29 B-20.44%
2019-12-31โ‚ฌ0.37 B21.34%
2018-12-31โ‚ฌ0.30 B-20.75%
2017-12-31โ‚ฌ0.39 B100.67%
2016-12-31โ‚ฌ0.19 B96.68%
2015-12-31โ‚ฌ99.08 M-11.15%
2014-12-31โ‚ฌ0.11 B115.38%
2013-12-31โ‚ฌ51.77 M-31.17%
2012-12-31โ‚ฌ75.22 M84.92%
2011-12-31โ‚ฌ40.67 M-35.01%
2010-12-31โ‚ฌ62.59 M32.92%
2009-12-31โ‚ฌ47.08 M3.32%
2008-12-31โ‚ฌ45.57 M-31.87%
2007-12-31โ‚ฌ66.89 M99.76%
2006-12-31โ‚ฌ33.48 M107.36%
2005-12-31โ‚ฌ16.15 M36.86%
2004-12-31โ‚ฌ11.8 M2850.3%
2003-12-31โ‚ฌ0.39 M329.95%
2002-12-31โ‚ฌ0.09 M214.46%
2001-12-31โ‚ฌ0.02 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ0.23 B-62.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.31 B 428.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.97 B 214.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.37 B 1,393.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.86 B 993.21%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ19.11 B 2,946.20%๐Ÿ‡บ๐Ÿ‡ธ USA